SCHEMBL13312397

SCHEMBL13312397

O=C1CC(=O)c2cccc(Br)c2N1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.41
CDK5 Q00535 2/20 0.41
CCNB2 O95067 2/20 0.41
CDK1 P06493 2/20 0.41
CCNB1 P14635 2/20 0.41
CCNB3 Q8WWL7 2/20 0.41
CDK5R1 Q15078 1/20 0.41
PIM1 P11309 1/20 0.41
CSNK1A1 P48729 1/20 0.41
ROCK1 Q13464 1/20 0.41
DYRK1A Q13627 1/20 0.41
LRRK2 Q5S007 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
AHR P35869 1/20 0.41
TDP2 O95551 3/20 0.39
CASP3 P42574 1/20 0.39
CASP7 P55210 1/20 0.39
CASP9 P55211 1/20 0.39
CASP6 P55212 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3906100 0.78 CCNB2 (0.49) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL8765618 0.78 SRD5A1 (0.41) AHRTDP2CASP3CASP7CASP9
SCHEMBL837443 0.77 AHR (0.61) GSK3BCDK5CCNB2CDK1CCNB1
SCHEMBL13312445 0.76 BRD4 (0.44) GSK3BCDK5PIM1CSNK1A1DYRK1A
SCHEMBL30049302 0.75 TDP2 (0.37) AHRTDP2CASP3CASP7CASP9
SCHEMBL10710535 0.74 AHR (0.53) GSK3BCDK5CCNB2CDK1CCNB1
SCHEMBL29783221 0.71 GSK3B (0.35) GSK3BCDK5CCNB2CDK1CCNB1
SCHEMBL935810 0.71 CES1 (0.60) CDK5PIM1CSNK1A1ROCK1DYRK1A
SCHEMBL29440762 0.71 CES1 (0.60) CDK5PIM1CSNK1A1ROCK1DYRK1A
SCHEMBL3715989 0.70 MAPT (0.64) CDK5PIM1CSNK1A1ROCK1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160314-A1 Small Molecule Inhibitors of Toll-Like Receptor 9 LIPFORD GRAYSON B 2010-06-24 US disclosed
US-20100160314-A1 Small Molecule Inhibitors of Toll-Like Receptor 9 LIPFORD GRAYSON B 2010-06-24 US disclosed
WO-2008030455-A2 SMALL MOLECULE INHIBITORS OF TOLL-LIKE RECEPTOR 9 COLEY PHARMACEUTICAL GROUP, INC. (US) 2008-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160314-A1 Small Molecule Inhibitors of Toll-Like Receptor 9 TLR9, TLR3, TLR1 GSK3B 332/4885CDK5 2972/4885CCNB2 4372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.